These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 14691589)

  • 1. Treatment of bleeding with recombinant factor VIIa in a patient with extensive burns.
    Bianchi A; Jackson D; Maitz P; Thanakrishnan G
    Thromb Haemost; 2004 Jan; 91(1):203-4. PubMed ID: 14691589
    [No Abstract]   [Full Text] [Related]  

  • 2. Traumatic haemorrhage: a role for recombinant factor VIIa?
    Spivey MH; Duffy MR
    Anaesthesia; 2009 Oct; 64(10):1141-2. PubMed ID: 19735409
    [No Abstract]   [Full Text] [Related]  

  • 3. A critical appraisal of the use of recombinant factor VIIa in acquired bleeding conditions.
    Mittal S; Watson HG
    Br J Haematol; 2006 May; 133(4):355-63. PubMed ID: 16643441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiographic documentation of the efficacy of recombinant activated factor VII (NovoSeven) to control diffuse bleeding in major trauma.
    Van Der Schueren B; Hammer F; Verschuren F; Hantson P; Deneys V; Hermans C
    Thromb Haemost; 2005 Dec; 94(6):1327-8. PubMed ID: 16411413
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of midgestational placental haemorrhage with recombinant factor VIIa.
    Krafft A; Asmis LM; Zimmermann R
    Thromb Haemost; 2008 Jul; 100(1):154-5. PubMed ID: 18612552
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful outcome of DIC and life-threatening bleeding in a toddler with neuroblastoma treated with recombinant activated factor VII.
    Hatzipantelis ES; Gombakis N; Sidi V; Papakonstantinou E; Koliouskas DE
    Intern Emerg Med; 2008 Jun; 3(2):171-3. PubMed ID: 18264677
    [No Abstract]   [Full Text] [Related]  

  • 7. [Can we still afford progress in intensive care medicine? Re: the article from DMW 1-2/2004].
    Kalenka A
    Dtsch Med Wochenschr; 2004 Jul; 129(31-32):1698-9; author reply 1699-70. PubMed ID: 15273924
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical significance of coagulation studies in predicting response to activated recombinant Factor VII in cardiac surgery patients.
    Lee AI; Campigotto F; Rawn JD; Neuberg D; Kaufman RM; Berliner N
    Br J Haematol; 2012 May; 157(3):397-400. PubMed ID: 22224596
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven).
    Tanaka KA; Waly AA; Cooper WA; Levy JH
    Anesthesiology; 2003 Jun; 98(6):1513-5. PubMed ID: 12766668
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombinant factor VIIa treatment for life-threatening haemoptysis.
    Yildirim H; Ucgun I; Yalcin AU; Gulbaş Z; Sahin G; Acikalin MF; Metintas M; Ak G
    Respirology; 2006 Sep; 11(5):652-4. PubMed ID: 16916342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recombinant activated factor VIIa in massive hemorrhage].
    Ingerslev J
    Ugeskr Laeger; 2005 Jun; 167(25-31):2737. PubMed ID: 16014254
    [No Abstract]   [Full Text] [Related]  

  • 12. The "off-label" role of recombinant factor VIIa in surgery: is the problem deficient evidence or defective concept?
    Al-Ruzzeh S; Navia JL
    J Am Coll Surg; 2009 Nov; 209(5):659-67. PubMed ID: 19854409
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of traumatic bleeding with recombinant factor VIIa.
    Kenet G; Walden R; Eldad A; Martinowitz U
    Lancet; 1999 Nov; 354(9193):1879. PubMed ID: 10584732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant factor VIIa in massive obstetric haemorrhage.
    Bhuskute N; Kritzinger S; Dakin M
    Eur J Anaesthesiol; 2008 Mar; 25(3):250-1. PubMed ID: 18226279
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical benefit of recombinant factor VIIa in management of bleeds and surgery in two brothers suffering from the Bernard-Soulier syndrome.
    Tefre KL; Ingerslev J; Sørensen B
    Haemophilia; 2009 Jan; 15(1):281-4. PubMed ID: 19149853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of severe sphincterotomy bleeding with recombinant activated factor VII.
    Garrido-Serrano A
    Gastrointest Endosc; 2012 Oct; 76(4):925-6. PubMed ID: 22985655
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of life-threatening hemorrhages and unsafe interventions in nonhemophiliac children by recombinant factor VIIa.
    Leblebisatan G; Sasmaz I; Antmen B; Yildizdas D; Kilinc Y
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):77-82. PubMed ID: 18838398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of intractable hemorrhage with recombinant factor VIIa during cranial vault reconstruction in an infant.
    Stricker PA; Petersen C; Fiadjoe JE; McCloskey JJ
    Paediatr Anaesth; 2009 Aug; 19(8):806-7. PubMed ID: 19624375
    [No Abstract]   [Full Text] [Related]  

  • 19. [Excessive blood loss after abdominal hysterectomy -- use of recombinant factor VIIa].
    Weilbach C; Scheinichen D; Jüttner B; Schürholz T; Piepenbrock S
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Nov; 39(11):672-5. PubMed ID: 15523581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful use of recombinant factor VIIa for severe surgical liver bleeding in a 5 month-old baby.
    Barro C; Wrobleski I; Piolat C; Cartal M; Dyon JF; Jacquier C; Andrini P; Polack B; Pernod G
    Haemophilia; 2004 Mar; 10(2):183-5. PubMed ID: 14962209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.